STADA: Purchase of a generics business in Switzerland successfully concluded
31/01/2012
STADA: Purchase of a generics business in Switzerland successfully concluded
Share:
Related Posts
Enzymatica and STADA sign partnership agreement for Germany and Austria
Enzymatica and STADA have entered into a partnership agreement regarding the launch and distribution of Enzymatica’s ColdZyme® oral-spray technology in Germany and Austria
STADA strikes deal with CuraTeQ for neutropenia biosimilars in Europe
STADA has entered into a marketing and distribution agreement with CuraTeQ focused on biosimilars, to bring to market two neutropenia biosimilars in Europe